India may start producing Russia's Sputnik V COVID-19 vaccine: Putin
1 min read 17 Nov 2020, 05:16 PM ISTRussia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results

India and China may start producing Russia's Sputnik V vaccine against COVID-19, the RIA news agency cited President Vladimir Putin as saying on Tuesday.
Putin also proposed that the creation of a vaccine research centre for BRICS countries - Brazil, Russia, India, China and South Africa - be sped up, TASS reported.
Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Nov. 11.
Russia licensed its Sputnik-V COVID-19 vaccine for domestic use in August before it started large-scale trials.
In September, Dr Reddy's and the Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.
As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr Reddy's upon regulatory approval in India.